A detailed history of Capital Counsel LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Capital Counsel LLC holds 62,206 shares of MRK stock, worth $5.99 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
62,206
Previous 62,183 0.04%
Holding current value
$5.99 Million
Previous $7.7 Million 8.24%
% of portfolio
0.3%
Previous 0.34%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$111.15 - $128.97 $2,556 - $2,966
23 Added 0.04%
62,206 $7.06 Million
Q1 2022

May 16, 2022

SELL
$73.51 - $82.4 $3,675 - $4,120
-50 Reduced 0.08%
62,183 $5.1 Million
Q4 2021

Feb 14, 2022

SELL
$72.28 - $90.54 $10,336 - $12,947
-143 Reduced 0.23%
62,233 $4.77 Million
Q3 2021

Nov 12, 2021

SELL
$71.68 - $78.83 $201,779 - $221,906
-2,815 Reduced 4.32%
62,376 $4.69 Million
Q2 2021

Aug 12, 2021

SELL
$70.31 - $77.77 $2.16 Million - $2.39 Million
-30,776 Reduced 32.07%
65,191 $5.07 Million
Q3 2020

Nov 16, 2020

SELL
$73.18 - $82.95 $7,318 - $8,295
-100 Reduced 0.1%
95,967 $7.96 Million
Q1 2020

May 15, 2020

SELL
$63.36 - $87.82 $146,741 - $203,391
-2,316 Reduced 2.35%
96,067 $7.39 Million
Q4 2019

Feb 14, 2020

BUY
$77.58 - $87.54 $58,185 - $65,655
750 Added 0.77%
98,383 $8.95 Million
Q3 2019

Nov 14, 2019

SELL
$76.08 - $82.93 $83,688 - $91,223
-1,100 Reduced 1.11%
97,633 $8.22 Million
Q3 2018

Nov 14, 2018

SELL
$57.69 - $67.84 $112,495 - $132,288
-1,950 Reduced 1.94%
98,733 $7 Million
Q1 2018

May 14, 2018

SELL
$50.96 - $59.23 $38,474 - $44,718
-755 Reduced 0.74%
100,683 $5.48 Million
Q4 2017

Feb 13, 2018

BUY
$51.62 - $61.64 $3,561 - $4,253
69 Added 0.07%
101,438 $5.71 Million
Q3 2017

Nov 14, 2017

BUY
$58.67 - $63.13 $5.95 Million - $6.4 Million
101,369
101,369 $6.49 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $244B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Capital Counsel LLC Portfolio

Follow Capital Counsel LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Counsel LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Counsel LLC with notifications on news.